146 related articles for article (PubMed ID: 31405334)
1. Metformin and sitagliptin combination therapy ameliorates polycystic ovary syndrome with insulin resistance through upregulation of lncRNA H19.
Wang Q; Shang J; Zhang Y; Zhou W
Cell Cycle; 2019 Oct; 18(19):2538-2549. PubMed ID: 31405334
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of microRNA-204 improves insulin resistance of polycystic ovarian syndrome via inhibition of HMGB1 and the inactivation of the TLR4/NF-κB pathway.
Jiang B; Xue M; Xu D; Song Y; Zhu S
Cell Cycle; 2020 Mar; 19(6):697-710. PubMed ID: 32089069
[TBL] [Abstract][Full Text] [Related]
3. SGLT-2 inhibitors enhance the effect of metformin to ameliorate hormonal changes and inflammatory markers in a rat PCOS model.
Mahmoud MM; Rashed LA; Soliman SA; Sayed SM; Kamel O; Kamar SS; Hussien RES
Physiol Rep; 2023 Nov; 11(22):e15858. PubMed ID: 37985173
[TBL] [Abstract][Full Text] [Related]
4. Spirulina versus metformin for controlling some insulin signaling pathway genes in induced polycystic ovary syndrome rat model.
El Leithy AA; Abozaid M; Al-Karmalawy AA; Mahmoud Allam R; Nourelden AZ; Amer RM; Abd El Azeem NH; Abo-Zeid FS
Gene; 2024 Aug; 921():148524. PubMed ID: 38735598
[TBL] [Abstract][Full Text] [Related]
5. N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway.
Jing YX; Li HX; Yue F; Li YM; Yu X; He JJ; Zhang XH
Gynecol Endocrinol; 2023 Oct; 39(1):2276167. PubMed ID: 37931646
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance, autophagy and apoptosis in patients with polycystic ovary syndrome: Association with PI3K signaling pathway.
Tong C; Wu Y; Zhang L; Yu Y
Front Endocrinol (Lausanne); 2022; 13():1091147. PubMed ID: 36589825
[TBL] [Abstract][Full Text] [Related]
7. Jiawei Buzhong Yiqi decoction ameliorates polycystic ovary syndrome via oocyte-granulosa cell communication.
Hu R; Huang Y; Geng Y; Liu Z; Li F; Zhang Z; Ma W; Song K; Dong H; Song Y; Zhang M
J Ethnopharmacol; 2024 Apr; 323():117654. PubMed ID: 38158097
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune activation of the GnRH receptor induces insulin resistance independent of obesity in a female rat model.
Li H; Zhang G; Guo Y; Deng J; Fischer H; Craig LB; Kem DC; Yu X
Physiol Rep; 2021 Jan; 8(24):e14672. PubMed ID: 33356018
[TBL] [Abstract][Full Text] [Related]
9. Genetic, hormonal and metabolic aspects of PCOS: an update.
De Leo V; Musacchio MC; Cappelli V; Massaro MG; Morgante G; Petraglia F
Reprod Biol Endocrinol; 2016 Jul; 14(1):38. PubMed ID: 27423183
[TBL] [Abstract][Full Text] [Related]
10. Electroacupuncture alleviates polycystic ovary syndrome-like symptoms through improving insulin resistance, mitochondrial dysfunction, and endoplasmic reticulum stress via enhancing autophagy in rats.
Peng Y; Guo L; Gu A; Shi B; Ren Y; Cong J; Yang X
Mol Med; 2020 Jul; 26(1):73. PubMed ID: 32698821
[TBL] [Abstract][Full Text] [Related]
11. Repurposing new drug candidates and identifying crucial molecules underlying PCOS Pathogenesis Based On Bioinformatics Analysis.
Dehghan Z; Mohammadi-Yeganeh S; Sameni M; Mirmotalebisohi SA; Zali H; Salehi M
Daru; 2021 Dec; 29(2):353-366. PubMed ID: 34480296
[TBL] [Abstract][Full Text] [Related]
12. Both
Alahmadi AA; Alzahrani AA; Ali SS; Alahmadi BA; Arab RA; El-Shitany NAE
Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31948119
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the N
Zou L; Li W; Xu D; Zhu S; Jiang B
J Ovarian Res; 2023 Aug; 16(1):157. PubMed ID: 37550765
[TBL] [Abstract][Full Text] [Related]
14. Myricetin ameliorates polycystic ovary syndrome in mice by brown adipose tissue activation.
Zheng N; Wang C; Li Y; Fu H; Hu T
Reproduction; 2024 Jun; 167(6):. PubMed ID: 38520750
[TBL] [Abstract][Full Text] [Related]
15. Glycyrrhizin ameliorates impaired glucose metabolism and ovarian dysfunction in a polycystic ovary syndrome mouse model.
Yang JP; Ullah A; Su YN; Otoo A; Adu-Gyamfi EA; Feng Q; Wang YX; Wang MJ; Ding YB
Biol Reprod; 2023 Jul; 109(1):83-96. PubMed ID: 37115805
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome.
Wang K; Li Y
Front Endocrinol (Lausanne); 2023; 14():1191759. PubMed ID: 37929034
[TBL] [Abstract][Full Text] [Related]
17. Traditional Chinese medicine formulae: A complementary method for the treatment of polycystic ovary syndrome.
Fu LW; Gao Z; Zhang N; Yang N; Long HY; Kong LY; Li XY
J Ethnopharmacol; 2024 Apr; 323():117698. PubMed ID: 38171464
[TBL] [Abstract][Full Text] [Related]
18. CAPN2 correlates with insulin resistance states in PCOS as evidenced by multi-dataset analysis.
Luo X; Dong Y; Zheng H; Zhou X; Rong L; Liu X; Bai Y; Li Y; Wu Z
J Ovarian Res; 2024 Apr; 17(1):79. PubMed ID: 38610028
[TBL] [Abstract][Full Text] [Related]
19. Lavender and metformin effectively propagate progesterone levels in patients with polycystic ovary syndrome: A randomized, double-blind clinical trial.
Simaei SR; Askari VR; Rostami M; Kamalinejad M; Farzaei MH; Morovati M; Heydarpour F; Jafari Z; Baradaran Rahimi V
Fitoterapia; 2024 Jan; 172():105720. PubMed ID: 37931721
[TBL] [Abstract][Full Text] [Related]
20. Metformin improves epigenetic modification involved in oocyte growth and embryo development in polycystic ovary syndrome mice model.
Amani Abkenari S; Safdarian L; Amidi F; Hosseini A; Aryanpour R; Salahi E; Sobhani A
Mol Reprod Dev; 2021 Dec; 88(12):817-829. PubMed ID: 34658106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
